Evidence map›Paper›PMID 38854416›Full record

ArticleRheumatology advances in practice2024

Pierre-Antoine Juge, Jeffrey A Sparks, Steven Gazal, Esther Ebstein, Raphaël Borie, Marie-Pierre Debray, Caroline Kannengiesser, Gregory C McDermott, Jing Cui, Keigo Hayashi and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Rheumatology advances in practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Pierre-Antoine JugeUniversité de Paris Cité, INSERM UMR 1152, Paris, France.
Jeffrey A SparksDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0002-5556-4618
Steven GazalDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Esther EbsteinService de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France.
Raphaël BorieUniversité de Paris Cité, INSERM UMR 1152, Paris, France.ORCID https://orcid.org/0000-0002-9906-0024
Marie-Pierre DebrayService de Radiologie, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France.
Caroline KannengiesserUniversité de Paris Cité, INSERM UMR 1152, Paris, France.
Gregory C McDermottDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.
Jing CuiDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.
Keigo HayashiDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.
Tracy J DoyleHarvard Medical School, Boston, MA, USA.
Coline H M van MoorselInterstitial Lung Disease Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
Joanne J van der VisInterstitial Lung Disease Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
Jan C GruttersInterstitial Lung Disease Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
Rachel KnevelDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Sascha L HeckertDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.ORCID https://orcid.org/0000-0002-3320-905X
Eirini VasarmidiLaboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University of Crete, Heraklion, Greece.
Katerina M AntoniouLaboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University of Crete, Heraklion, Greece.
Annette H M van der Helm van MilDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Catherine BoileauService de Génétique, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France.ORCID https://orcid.org/0000-0002-0371-7539
Bruno CrestaniUniversité de Paris Cité, INSERM UMR 1152, Paris, France.
Philippe DieudéUniversité de Paris Cité, INSERM UMR 1152, Paris, France.ORCID https://orcid.org/0000-0002-4814-0307

Funding

MECHANISMS OF ARTHRITIC &DERMATOLOGY DISORDERST32AR007530 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Michael B. Brenner, Ellen M Gravallese · 1986 to 2026
$10.4M
NIAMS NIH HHS T32 AR007530
6 · The paper itself

Abstract

Objective: Recently, a genome-wide association study identified an association between RA-associated interstitial lung disease (ILD) and Methods: In this genetic case-control association study, patients with RA and ILD and controls with RA and no ILD were included from France, the USA and the Netherlands. Only cases and controls from European genetic ancestries determined by principal components analysis were included in the analyses. RA was defined by the 1987 ACR or 2010 ACR/EULAR criteria and ILD by chest high-resolution CT scan, except in the control dataset from the Netherlands, where the absence of ILD was determined by chart review. Patients were genotyped for Results: Among the 883 patients included, 322 were RA-ILD cases (36.5%). Conclusion: Our findings did not support a contribution of

Indexed as

geneticinterstitial lung diseaserheumatoid arthritis

Identifiers

PMID38854416
PMCPMC11157136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.